logo

Biotechnology & Drugs News

Share

Addex's Dipraglurant Blepharospasm Phase 2 Feasibility Clinical Study Fails To Meet Objectives

Verrica Gets CRL From FDA For VP-102 NDA For The Treatment Of Molluscum Contagiosum

UniQure Says FDA Accepts BLA For Etranacogene Dezaparvovec Under Priority Review